News & Articles

Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection

AstraZeneca, Exactmer, Novartis and UK Research & Innovation aim to make the UK the first country in the world to deliver this pioneering production process at a large scale

The testing capacity provided by the Fluidigm system aims to help the university limit the spread of the virus

New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific

The adjustable tip spacing pipettes from INTEGRA are used to increase efficiency in the production of venom-based screening assays

RNA controls can help avoid false negative results

Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing

The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination

Dr. Santu Saha shares his team’s groundbreaking work to develop improved cancer treatments to avoid the potential side effects of chemotherapy

The device is a high-throughput-compatible neuronal compartmentalization and co-culture microfluidic platform

New crowdsourcing project to examine the ‘Translocation of Complex Macromolecules Across the Intestinal Epithelial Barrier’

This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2

Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others

Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay

Join our webinar series and roundtable discussion on Tuesday, February 2, to find out more about an innovative technology that promises to increase kinetic workflow throughput

In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy

Cabenuva allows virologically suppressed adults with HIV to maintain viral suppression with 12 dosing days per year

Developed in partnership with Rosetta Biosciences, discovery enables simultaneous detection of multiple targets, furthering next generation of diagnostics

The strategic collaboration aims to accelerate clinical trials and drive critical developments for promising COVID-19 treatments

The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years

The new institute aims to meet the urgent need to do more research into the antimicrobial resistance

Panel supports research to distinguish between types of chronic inflammatory airway disease including asthma, COPD and IPF